HQY - HealthEquity, Inc.
NASDAQ
->
Healthcare
->
Health Information Services
Draper,
United States
Type: Equity
HQY price evolution
HQY
| (in millions $) | 1 May 2025 | 31 Jan 2025 | 31 Aug 2024 | 30 Jul 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $326.89 | |||
| Short term investments | ||||
| Net receivables | $108.45 | $106.22 | ||
| Inventory | ||||
| Total current assets | $495.63 | $404.9 | ||
| Long term investments | ||||
| Property, plant & equipment | $51.08 | $53.19 | ||
| Goodwill & intangible assets | $2902.36 | |||
| Total noncurrent assets | $3018.84 | |||
| Total investments | ||||
| Total assets | $3514.47 | $3246.48 | ||
| Current liabilities | ||||
| Accounts payable | $10.56 | $18.17 | ||
| Deferred revenue | ||||
| Short long term debt | $9.89 | |||
| Total current liabilities | $120.91 | $92.22 | ||
| Long term debt | $1101.4 | $925.67 | ||
| Total noncurrent liabilities | $1236.52 | |||
| Total debt | $1157.45 | |||
| Total liabilities | $1357.43 | $1148.7 | ||
| Shareholders' equity | ||||
| Retained earnings | $270.26 | $234.44 | ||
| Other shareholder equity | ||||
| Total shareholder equity | $2157.04 | |||
| (in millions $) | 31 Jan 2025 | 31 Dec 2023 | 3 Mar 2023 | 31 Dec 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $403.98 | $254.27 | $225.41 | |
| Short term investments | ||||
| Net receivables | $104.89 | $96.83 | $87.43 | |
| Inventory | ||||
| Total current assets | $557.44 | $382.89 | $351.34 | |
| Long term investments | ||||
| Property, plant & equipment | $54.39 | $69.32 | $86.98 | |
| Goodwill & intangible assets | $2484.09 | $2584.5 | $2618.97 | |
| Total noncurrent assets | $2606.35 | $2706.01 | $2755.76 | |
| Total investments | ||||
| Total assets | $3163.79 | $3088.9 | $3107.1 | |
| Current liabilities | ||||
| Accounts payable | $12.04 | $13.9 | $27.54 | |
| Deferred revenue | ||||
| Short long term debt | $9.4 | $27.66 | $20.92 | |
| Total current liabilities | $117.09 | $131.06 | $153.19 | |
| Long term debt | $923.74 | $907.84 | $987.31 | |
| Total noncurrent liabilities | $1011.68 | $1062.2 | $1101.34 | |
| Total debt | $933.14 | $994.49 | $1008.23 | |
| Total liabilities | $1128.77 | $1193.26 | $1254.53 | |
| Shareholders' equity | ||||
| Retained earnings | $205.63 | $149.92 | $176.06 | |
| Other shareholder equity | ||||
| Total shareholder equity | $2035.02 | $1895.64 | $1852.58 | |
| (in millions $) | 1 May 2025 | 31 Jan 2025 | 31 Aug 2024 | 30 Jul 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $299.93 | |||
| Cost of revenue | ||||
| Gross Profit | $204.05 | |||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $143.35 | |||
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $10.79 | |||
| Interest expense | -$12.32 | |||
| Net income | ||||
| Net income | $35.82 | |||
| Income (for common shares) | ||||
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $999.59 | $861.75 | $756.56 | $733.57 |
| Cost of revenue | $376.95 | $371.66 | $332.85 | $318.24 |
| Gross Profit | $622.64 | $490.09 | $423.71 | $415.33 |
| Operating activities | ||||
| Research & development | $218.81 | $193.38 | $157.36 | $124.81 |
| Selling, general & administrative | $182.93 | $164.48 | $142.98 | $134.46 |
| Total operating expenses | $504.94 | $481.03 | $447.94 | $381.32 |
| Operating income | $117.7 | $9.06 | -$24.24 | $34.01 |
| Income from continuing operations | ||||
| EBIT | $130.5 | $10.33 | -$30.17 | $39.02 |
| Income tax expense | $19.33 | -$11.95 | -$22.45 | -$4.69 |
| Interest expense | $55.45 | $48.42 | $36.57 | $34.88 |
| Net income | ||||
| Net income | $55.71 | -$26.14 | -$44.29 | $8.83 |
| Income (for common shares) | $55.71 | -$26.14 | -$44.29 | $8.83 |
| (in millions $) | 31 Aug 2024 | 30 May 2024 | 2 Mar 2024 | 1 Dec 2023 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$479.03 | -$269.95 | -$46.07 | -$34.82 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $228.39 | $51.77 | -$47.04 | -$51.17 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$77.09 | -$152.75 | $149.71 | $79.72 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $55.71 | -$26.14 | -$44.29 | $8.83 |
| Operating activities | ||||
| Depreciation | $153.08 | $161.2 | $137.19 | $115.9 |
| Business acquisitions & disposals | -$3.26 | -$70.58 | -$504.53 | |
| Stock-based compensation | $77.15 | $62.61 | $52.75 | $42.86 |
| Total cash flows from operations | $242.83 | $150.65 | $141 | $181.62 |
| Investing activities | ||||
| Capital expenditures | -$42.82 | -$48.54 | -$71.62 | -$64.59 |
| Investments | $2.37 | |||
| Total cash flows from investing | -$46.07 | -$119.13 | -$639.25 | -$96.96 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $6.47 | $6.68 | $466.39 | $295.35 |
| Net borrowings | -$54.38 | -$8.75 | -$65.05 | -$239.06 |
| Total cash flows from financing | -$47.04 | -$2.67 | $394.86 | $52.42 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $149.71 | $28.85 | -$103.39 | $137.08 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |